Information about the COVID-19 Vaccine

If I already had COVID-19 do I need to receive the COVID-19 vaccine?

If you have had COVID-19, you should still receive a vaccine. Antibodies in individuals who have had COVID-19 only lasts about 90 days.

Do the vaccines created for COVID-19 use weakened or inactivated versions or components of COVID-19?

Neither of the vaccines use weakened or inactivated versions or components of COVID-19. mRNA can be described as instructions that are used to make a unique feature of COVID-19. Since only a very specific set of instructions is used, it does not harm the person or impact someone’s genetic makeup.

Why are we using a newer kind of vaccine?

While mRNA vaccines are new, they have been studied for decades by researchers. Early stage clinical trials and studies using mRNA include Zika, influenza, rabies, and cancer. mRNA vaccines have many benefits, including the ability to not use infectious elements, shorter manufacturing times, and possibility to target many diseases.

Click here to view a video about mRNA vaccines.

Is there more than one vaccine currently available for COVID-19?

There are currently two vaccines that have been authorized for emergency use in the United States for COVID-19. The names of these vaccines are Moderna and Pfizer. Both vaccines require two shots.

How have the two vaccines that are currently in use for COVID-19  been shown to be safe and effective?

Both vaccines went through clinical trials and were held to very high standards created by the United States Food and Drug Administration (FDA) in order to qualify for an Emergency Use Authorization (EUA). The Advisory Committee on Immunization Practices (ACIP), which is made up of medical and public health experts, also reviews the information before making recommendations to the CDC regarding the use of the vaccine. Once final approval is given, many vaccine safety monitoring systems watch for side effects. If an unexpected event is found, it is further investigated to ensure that the benefits continue to outweigh the risks for people receiving the vaccines.

Questions? Contact us at